Literature DB >> 20140965

Phenotypic manifestations and management of hyperostosis cranialis interna, a hereditary bone dysplasia affecting the calvaria and the skull base.

J J Waterval1, R J Stokroos, N J C Bauer, R B J De Bondt, J J Manni.   

Abstract

Hyperostosis cranialis interna is a hereditary bone disorder that is characterized by endosteal hyperostosis and osteosclerosis of the calvaria and the skull base (OMIM 144755). The progressive bone overgrowth causes entrapment and dysfunction of cranial nerves I, II, V, VII, and VIII, its first symptoms often presenting during the second decade. This study analyzes the clinical course of 13 affected individuals of three related families (32 individuals). The disorder appears to have an autosomal-dominant transmission pattern. Facial and vestibulocochlear nerve dysfunction are most frequently reported. Surgical decompression of the accessible impaired cranial nerves is advised in the early symptomatic period or even in the presymptomatic period in high-risk individuals. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20140965     DOI: 10.1002/ajmg.a.33205

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Imaging features and progression of hyperostosis cranialis interna.

Authors:  J J Waterval; T M van Dongen; R J Stokroos; B-J De Bondt; M N Chenault; J J Manni
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

2.  Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET.

Authors:  Jérôme J Waterval; Thijs M A Van Dongen; Robert J Stokroos; Jaap G J Teule; Gerrit J Kemerink; Boudewijn Brans; Fred H M Nieman; Johannes J Manni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-16       Impact factor: 9.236

3.  Conditional mouse models support the role of SLC39A14 (ZIP14) in Hyperostosis Cranialis Interna and in bone homeostasis.

Authors:  Gretl Hendrickx; Vere M Borra; Ellen Steenackers; Timur A Yorgan; Christophe Hermans; Eveline Boudin; Jérôme J Waterval; Ineke D C Jansen; Tolunay Beker Aydemir; Niels Kamerling; Geert J Behets; Christine Plumeyer; Patrick C D'Haese; Björn Busse; Vincent Everts; Martin Lammens; Geert Mortier; Robert J Cousins; Thorsten Schinke; Robert J Stokroos; Johannes J Manni; Wim Van Hul
Journal:  PLoS Genet       Date:  2018-04-05       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.